Recombinant expression of proteoglycans in mammalian cells. Utility and advantages of the vaccinia virus/T7 bacteriophage hybrid expression system.
McQuillan
D J
DJ
LifeCell Corporation, Branchburg, NJ, USA.
Seo
N S
NS
Hocking
A M
AM
McQuillan
C I
CI
D000595:Amino Acid Sequence; D000818:Animals; D017123:Bacteriophage T7 / Q000235:genetics*; D001483:Base Sequence; D002460:Cell Line; D002846:Chromatography, Affinity; D004274:DNA, Recombinant / Q000235:genetics; D012321:DNA-Directed RNA Polymerases / Q000235:genetics; D015870:Gene Expression; D005822:Genetic Vectors; D006801:Humans; D008322:Mammals; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D011509:Proteoglycans / Q000096:biosynthesis* / Q000235:genetics*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D011995:Recombination, Genetic; D014162:Transfection; D014616:Vaccinia virus / Q000235:genetics*; D010948:Viral Plaque Assay; D014764:Viral Proteins; D014776:Virus Cultivation
D004274:DNA, Recombinant; D011509:Proteoglycans; D011994:Recombinant Proteins; D014764:Viral Proteins; C062210:bacteriophage T7 RNA polymerase; D012321:DNA-Directed RNA Polymerases